NVO261113C00045000
NVO Nov 13 2026 45.00 Call
optionOPRA
EODOct 22, 2026
0.32USD+23.077%(+0.06)75Vol470OI
Loading…
Underlying
Underlying Price
$38.90
Type
Call
Strike
45
Expiration
Nov 13, 2026
DTE
20d
Moneyness
OTM
Intrinsic
$0.00
NVO 45 Call Across Expirations
| Expiration | DTE | Last | Change | Vol | Open Int |
|---|---|---|---|---|---|
| Oct 23, 2026 | -1d | $0.01 | +0.00% | 4 | 107 |
| Oct 30, 2026 | 6d | $0.02 | +0.00% | 108 | 1,363 |
| Nov 6, 2026 | 13d | $0.23 | +15.00% | 37 | 519 |
| Nov 13, 2026 | 20d | $0.32 | +23.08% | 75 | 470 |
| Nov 20, 2026 | 27d | $0.32 | +3.23% | 608 | 6,542 |
| Nov 27, 2026 | 34d | $0.42 | +16.67% | 9 | 81 |
| Dec 18, 2026 | 55d | $0.66 | +6.45% | 153 | 7,174 |
| Jan 15, 2027 | 83d | $1.02 | +9.68% | 1,110 | 14,667 |
| Mar 19, 2027 | 146d | $2.12 | +11.58% | 128 | 3,722 |
| Jun 17, 2027 | 236d | $3.01 | +7.50% | 31 | 4,451 |
| Sep 17, 2027 | 328d | $3.80 | +2.70% | 4 | 1,656 |
| Dec 17, 2027 | 419d | $4.75 | +1.06% | 9 | 8,794 |
| Jan 21, 2028 | 454d | $4.85 | -3.00% | 27 | 8,414 |
| Jun 16, 2028 | 601d | $5.75 | -5.74% | 1 | 125 |
| Dec 15, 2028 | 783d | $7.70 | +5.19% | 6 | 1,440 |
| Jan 19, 2029 | 818d | $7.62 | +0.93% | 10 | 582 |
NVO Nearby Strikes · Nov 13, 2026
| Strike | Last | Change | Vol | Open Int | Moneyness |
|---|---|---|---|---|---|
| 39 C | $1.94 | -10.60% | 30 | 282 | OTM |
| 40 C | $1.57 | +18.94% | 34 | 166 | OTM |
| 41 C | $1.14 | +21.28% | 40 | 280 | OTM |
| 42 C | $0.83 | +9.21% | 11 | 190 | OTM |
| 43 C | $0.60 | +20.00% | 213 | 741 | OTM |
| 44 C | $0.45 | +21.62% | 3 | 126 | OTM |
| 45 C | $0.32 | +23.08% | 75 | 470 | OTM |
| 46 C | $0.18 | -18.18% | 2 | 112 | OTM |
| 47 C | $0.11 | -21.43% | 2 | 30 | OTM |
| 48 C | $0.09 | -30.77% | 1 | 28 | OTM |
| 50 C | $0.06 | -25.00% | 2 | 3 | OTM |
| 55 C | $0.02 | -33.33% | 1 | 322 | OTM |
NVO Profile
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, with production facilities in nine countries and affiliates or offices in five countries.